‘Failure was Never an Option’: South Africa’s mRNA ‘Hub’ Awarded Good Manufacturing Practice Certification

drug approval expired 85% Health

Afrigen Biologics in South Africa has received Good Manufacturing Practice certification for its mRNA vaccine facility in Cape Town, becoming the first African facility certified to manufacture investigational biological products for clinical trials. This marks a significant milestone in vaccine manufacturing capabilities in Africa.

🇿🇦 Location: Cape Town — Sources: 1 — First seen: — Last seen:
Afrigen Biologics mRNA vaccine Good Manufacturing Practice Cape Town clinical trials

Linked Entities

Afrigen Biologics

organization involved

Cape Town

location involved 🇿🇦

Contributing Articles